This topic contains a solution. Click here to go to the answer
« previous next »

Author Question: A patient is being treated for chemotherapy-induced nausea and vomiting (CINV) with ondansetron ... (Read 52 times)

tingc95

  • Hero Member
  • *****
  • Posts: 556
on: Jul 23, 2018
A patient is being treated for chemotherapy-induced nausea and vomiting (CINV) with ondansetron (Zofran) and dexamethasone.
 
  The patient reports getting relief during and immediately after chemotherapy but has significant nausea and vomiting several days after each chemotherapy treatment. What will the nurse do?
  a. Contact the provider to discuss increasing the dose of ondansetron.
  b. Suggest giving prolonged doses of dexamethasone.
  c. Suggest adding aprepitant (Emend) to the medication regimen.
  d. Tell the patient to ask the provider about changing the ondansetron to aprepitant.

Question 2

A patient is receiving intravenous promethazine (Phenergan) 25 mg for postoperative nausea and vomiting. What is an important nursing action when giving this drug?
 
  a. Giving the dose as an IV push over 3 to 5 minutes
  b. Infusing the dose with microbore tubing and an infusion pump
  c. Observing the IV insertion site frequently for patency
  d. Telling the patient to report dry mouth and sedation


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bob

  • Sr. Member
  • ****
  • Posts: 343
Reply #1 on: Jul 23, 2018
Answer to Question 1

ANS: C
The current regimen of choice for patients taking highly emetogenic drugs consists of three agents: aprepitant plus dexamethasone plus a 5-HT3 antagonist, such as ondansetron. Aprepitant has a prolonged duration of action and can prevent delayed CINV as well as acute CINV. Increasing the dose of ondansetron will not help treat the delayed CINV. Glucocorticoids should be given intermittently and for short periods to avoid side effects. Changing the ondansetron to aprepitant is not recommended.

Answer to Question 2

ANS: C
If IV administration must be done with this drug, it should be given through a large-bore, freely flowing line. The site should be monitored closely for local burning or pain or any sign of extravasation, which can cause abscess formation, tissue necrosis, and gangrene requiring amputation. Giving the medication as a rapid IV push or through microbore tubing does not adequately slow the infusion or dilute the drug. Dry mouth and sedation are expected side effects of this drug and are not dangerous.


tingc95

  • Member
  • Posts: 556
Reply 2 on: Jul 23, 2018
:D TYSM

adf223

  • Member
  • Posts: 304
Reply 3 on: Yesterday
Wow, this really help

« previous next »
 

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

Every 10 seconds, a person in the United States goes to the emergency room complaining of head pain. About 1.2 million visits are for acute migraine attacks.

Did you know?

More than 20 million Americans cite use of marijuana within the past 30 days, according to the National Survey on Drug Use and Health (NSDUH). More than 8 million admit to using it almost every day.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

According to the National Institute of Environmental Health Sciences, lung disease is the third leading killer in the United States, responsible for one in seven deaths. It is the leading cause of death among infants under the age of one year.

Urinary catheterization. The procedure involves the insertion of a flexible tube, or catheter, throu Urinary catheterization. The procedure involves the insertion of a flexible tube, or catheter, throu
The patient is undergoing an allergy skin test by receiving subdermal inoculations of allergens. Inf The patient is undergoing an allergy skin test by receiving subdermal inoculations of allergens. Inf
Pigmented bands in nail of patient with dark skin Pigmented bands in nail of patient with dark skin
PET Scans of a Patient with Parkinsonian Symptoms PET Scans of a Patient with Parkinsonian Symptoms
Conditions Treated by Physical Therapy Cont Conditions Treated by Physical Therapy Cont
System of a patient in shock System of a patient in shock
Video: DNA Replication Factory and Protein

For a complete list of videos, visit our video library